05
June
2026
|
16:13 PM
America/New_York

New ACR guidelines for juvenile idiopathic arthritis favor DMARDs over NSAIDs

Healio reported on new 2026 guidelines from the American College of Rheumatology featuring insight from Karen Brandt Onel, MD, pediatric rheumatologist at HSS.

The American College of Rheumatology recommends early and aggressive treatment for juvenile idiopathic arthritis, and disease-modifying therapies are recommended over NSAIDs and glucocorticoids.

“If a child has damage from untreated or undertreated arthritis, that will follow them forever,” said Dr. Onel. "We know that some children with get off medication over time as the arthritis regresses. However, if damage has already happened that cannot be fixed.”

Read the full article at healio.com